The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

Amr Ali(Discovery Centre), Theodoros Tsakiridis(Juravinski Cancer Centre)
Communications Biology
September 8, 2023
Cited by 60


Related Papers